Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion (068270 KP)
Watchlist
21
Analysis
Health Care
•
South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Celltrion Inc
•
19 Jul 2017 06:14
JNJ's REMICADE Holds: PFE's Results To Confirm
Johnson & Johnson (JNJ US) reported Q2 2017 results today (quotes from earnings call are below). US revenue for REMICADE (reference product for...
Kemp Dolliver, CFA
511 Views
Share
bearish
•
Celltrion Healthcare
•
17 Jul 2017 13:39
Celltrion Healthcare IPO Part 5 - Regulatory Concerns & Possible M&A Options
Korea's Anti-Trust Law now says that any business group (those so-called chaebols or large conglomerates) with combined assets of ₩10tril are...
Sanghyun Park
Follow
186 Views
Share
bullish
•
Celltrion Healthcare
•
13 Jul 2017 11:26
Valuation of Celltrion + Celltrion Healthcare Is Not as Expensive as Samsung Biologics
Celltrion Healthcare (091990 KS) (CH) is raising US$701 - 884m in its upcoming IPO. Proceeds raised will be used to fund general working capital,...
Zhen Zhou, Toh
295 Views
Share
bearish
•
Celltrion Healthcare
•
12 Jul 2017 13:51
Celltrion Healthcare IPO Part 4 - Valuation & Pricing Debate
Celltrion Healthcare (091990 KS)'s bookbuilding is now in progress among overseas investors, and local bookbuilding will begin tomorrow and end on...
Sanghyun Park
Follow
275 Views
Share
bearish
•
Celltrion Healthcare
•
03 Jul 2017 11:54
Celltrion Healthcare IPO Part 3 - What Local Institutions Seem to Have in Mind
Celltrion Healthcare (091990 KS) officials are currently meeting Korea's local institutional investors for its IPO. Local roadshow began on June...
Sanghyun Park
Follow
279 Views
Share
First
Previous
78
79
80
81
82
83
84
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.35.0
x